Breaking News Instant updates and real-time market news.

LGND

Ligand

$104.09

-4.01 (-3.71%)

, NVS

Novartis

09:27
12/22/16
12/22
09:27
12/22/16
09:27

Ligand announces license, supply agreements for Captisol-enabled trametinib

Ligand Pharmaceuticals (LGND) announces it has entered into global license and supply agreements with Novartis for the development and commercialization of a Captisol-enabled oral liquid formulation of trametinib, a kinase inhibitor currently indicated as a single agent or in combination with dabrafenib, for the treatment of patients with unresectable or metastatic melanoma with BRAF V600 mutation. Under the terms of the license, Ligand will be eligible to receive a license fee, royalties on future net sales, and revenue from Captisol material sales. Novartis (NVS) will be responsible for all costs related to the program.

LGND

Ligand

$104.09

-4.01 (-3.71%)

NVS

Novartis

  • 19

    Jan

  • 01

    Feb

  • 21

    Feb

LGND Ligand
$104.09

-4.01 (-3.71%)

09/07/16
09/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Hold from Underperform at Jefferies with analyst Jason Gammel citing valuation and improving financial metrics. 2. DineEquity (DIN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Chris O'Cull saying the stock has reached a good entry point, while its risk/reward ratio is "compelling." 3. Gaming and Leisure Properties (GLPI) upgraded to Overweight at Morgan Stanley. 4. Aviva (AV) upgraded to Buy from Neutral at UBS with the firm saying the company is positioned to be the risk-adjusted dividend leader in the sector. 5. Ligand (LGND) upgraded to Hold from Sell at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
HCWC
10/05/16
NO CHANGE
Target $160
HCWC
Buy
Ligand price target raised to $160 from $146 at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther raised her price target for Ligand Pharmaceuticals to $160 citing three recent positive events, namely positive Phase II focal segmental glomerulosclerosis data from partner Retrophin, the beginning of a Phase II clinical trial with LGD-6972 for the treatment of type 2 diabetes and the licensing of several therapeutic programs to Seelos. Werther keeps a Buy rating on Ligand.
10/10/16
ROTH
10/10/16
NO CHANGE
Target $154
ROTH
Buy
Ligand price target raised to $154 after Carnexiv approval at Roth Capital
Roth Capital analyst Joseph Pantginis raised his price target on Ligand to $154 from $150 after partner Lundbeck announced that the FDA approved Carnexiv injection as a short-term replacement therapy for oral carbamazepine formulations in adults with certain seizure types. Ligand will receive a $1.25M milestone payment this quarter and is entitled to receive a 2.75% royalty on sales of the drug, noted Pantginis, who keeps a Buy rating on Ligand shares.
11/07/16
SPHN
11/07/16
NO CHANGE
Target $125
SPHN
Overweight
Ligand price target lowered to $125 from $150 at Stephens
Stephens analyst Drew Jones lowered his price target for Ligand to $125 from $150 on valuation. The analyst notes that the company reported mixed Q3 results as revenue softness led to lowered guidance for the year. Nonetheless, he reiterates an Overweight rating on the shares.
NVS Novartis

12/19/16
MAXM
12/19/16
NO CHANGE
Target $43
MAXM
Buy
Drop outs of Neulasta competitors may benefit Coherus in EU, says Maxim
Maxim analyst Jason McCarthy noted that Gedeon Richter and STADA Arzneimittel AG have withdrawn their respective MAAs for biosimilar Neulasta, which he said may put Coherus Biosciences in a good position in terms of the competitive landscape for the drug in Europe. Novartis (NVS) and Mylan (MYL) had filed before Coherus and Apotex may file in 2017, noted McCarthy. In the U.S., Novartis' BLA was rejected by the FDA and Coherus could have a two-year head start in commercialization of biosimilar Neulasta, added the analyst, who has a Buy rating and $43 price target on Coherus shares.
12/20/16
HCWC
12/20/16
NO CHANGE
Target $18
HCWC
Buy
Conatus price target doubled to $18 after Novartis pact at H.C. Wainwright
H.C. Wainwright analyst Ed Arce called Conatus' (CNAT) license and collaboration agreement with Novartis (NVS) a "transformational" deal that he believes ends any uncertainty about whether sufficient financial resources exist to support emricasan's full development. The analyst, who is positive on the deal both strategically and financially and predicted shares Conatus will trade up "at least 100% today," raised his price target on the stock to $18 from $9 and affirmed his Buy rating.
12/20/16
STFL
12/20/16
NO CHANGE
STFL
Conatus price target raised to $7 from $5 at Stifel
Stifel analyst Stephen Willey says that Novartis' (NVS) decision to collaborate with Conatus (CNAT) on its emricasan treatment marks a positive turning point for Conatus. Willey notes that the deal provides Conatus with funding and the opportunity to "pursue combination development with Novartis' FXR agonist LJN452," which he believes has synergies with emricasan. The analyst keeps a Buy rating on Conatus.
12/20/16
RHCO
12/20/16
NO CHANGE
RHCO
Conatus price target raised to $26 from $17 at SunTrust
After Conatus (CNAT) announced a partnership deal with Novartis (NVS), SunTrust analyst John Boris says the deal is "transformational" for Conatus. The analyst thinks that the deal will be worth about $1B to Conatus. He believes that the deal makes strategic sense to Conatus because of the potential synergies in the mechanism of action between its NASH treatment and that of Novartis (NVS). Boris keeps a Buy rating on Conatus.

TODAY'S FREE FLY STORIES

03:30
08/23/17
08/23
03:30
08/23/17
03:30
General news
FX Action: USD-CAD has lifted to the upper 1.25s »

FX Action: USD-CAD has…

03:25
08/23/17
08/23
03:25
08/23/17
03:25
General news
FX Action: USD-CAD has lifted to the upper 1.25s »

FX Action: USD-CAD has…

02:45
08/23/17
08/23
02:45
08/23/17
02:45
General news
FX Update: The dollar is trading moderately firmer »

FX Update: The dollar is…

LOW

Lowe's

$75.82

1.97 (2.67%)

, EV

Eaton Vance

$47.16

0.58 (1.25%)

20:25
08/22/17
08/22
20:25
08/22/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

LOW

Lowe's

$75.82

1.97 (2.67%)

EV

Eaton Vance

$47.16

0.58 (1.25%)

AEO

American Eagle

$11.21

0.59 (5.56%)

EXPR

Express

$5.49

0.14 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 11

    Sep

  • 12

    Sep

  • 13

    Sep

  • 14

    Sep

  • 15

    Sep

  • 21

    Nov

T

AT&T

$37.98

0.4 (1.06%)

, TWX

Time Warner

$101.80

-0.31 (-0.30%)

19:14
08/22/17
08/22
19:14
08/22/17
19:14
Hot Stocks
Mexico regulators approve AT&T-Time Warner deal »

The Instituto Federal de…

T

AT&T

$37.98

0.4 (1.06%)

TWX

Time Warner

$101.80

-0.31 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

REGI

Renewable Energy

$11.20

0.1 (0.90%)

18:50
08/22/17
08/22
18:50
08/22/17
18:50
Hot Stocks
Renewable Energy CEO: Commerce Dept. move 'victory' for job creation »

The U.S Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

INTC

Intel

$34.65

-0.27 (-0.77%)

18:37
08/22/17
08/22
18:37
08/22/17
18:37
Hot Stocks
Former Intel CFO Stacy Smith to retire at the end of January, 2018 »

In an email, Intel CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

COL

Rockwell Collins

$124.29

0.6 (0.49%)

18:36
08/22/17
08/22
18:36
08/22/17
18:36
Upgrade
Rockwell Collins rating change at Vertical Research »

Rockwell Collins upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$92.95

1.19 (1.30%)

18:24
08/22/17
08/22
18:24
08/22/17
18:24
Hot Stocks
Salesforce CEO says closed large deal with Veterans Administration »

Says federal government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

WWR

Westwater Resources

$1.32

-0.14 (-9.59%)

18:16
08/22/17
08/22
18:16
08/22/17
18:16
Hot Stocks
Westwater Resources acquires water rights for Columbus Basin Project in Nevada »

Westwater Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTO

ZTO Express

$14.01

0.11 (0.79%)

18:03
08/22/17
08/22
18:03
08/22/17
18:03
Earnings
Breaking Earnings news story on ZTO Express »

ZTO Express sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ZTO

ZTO Express

$14.01

0.11 (0.79%)

18:02
08/22/17
08/22
18:02
08/22/17
18:02
Earnings
ZTO Express reports Q2 earnings per ADS 15c, consensus 14c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

URI

United Rentals

$112.44

4.04 (3.73%)

, CMI

Cummins

$153.10

1.04 (0.68%)

17:48
08/22/17
08/22
17:48
08/22/17
17:48
Hot Stocks
United Rentals acquires power equipment assets from Cummins »

United Rentals (URI) has…

URI

United Rentals

$112.44

4.04 (3.73%)

CMI

Cummins

$153.10

1.04 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

MXIM

Maxim Integrated

$44.39

0.68 (1.56%)

, LZB

La-Z-Boy

$31.25

0.1 (0.32%)

17:40
08/22/17
08/22
17:40
08/22/17
17:40
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Maxim Integrated…

MXIM

Maxim Integrated

$44.39

0.68 (1.56%)

LZB

La-Z-Boy

$31.25

0.1 (0.32%)

CREE

Cree

$23.03

0.46 (2.04%)

VNET

21Vianet

$4.58

0.03 (0.66%)

CRM

Salesforce

$92.95

1.19 (1.30%)

RTNB

root9B Technologies

$2.98

1.72 (136.51%)

RARE

Ultragenyx

$58.85

1.94 (3.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 23

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 16

    Nov

CRM

Salesforce

$92.95

1.19 (1.30%)

17:40
08/22/17
08/22
17:40
08/22/17
17:40
Hot Stocks
Salesforce says sees FY18 margin up 125-150 bps »

Sees "slight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

MXIM

Maxim Integrated

$44.39

0.68 (1.56%)

17:34
08/22/17
08/22
17:34
08/22/17
17:34
Hot Stocks
Maxim Integrated names Sumeet Gagneja principal accounting officer »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

CTIC

CTI BioPharma

$3.30

0.01 (0.30%)

17:33
08/22/17
08/22
17:33
08/22/17
17:33
Hot Stocks
CTI BioPharma: Chief Business Officer Matthew Plunkett resigns »

Effective August 22,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$47.84

0.51 (1.08%)

17:32
08/22/17
08/22
17:32
08/22/17
17:32
Syndicate
Breaking Syndicate news story on Unum Group »

Unum Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FTK

Flotek

$5.50

-0.1 (-1.79%)

17:29
08/22/17
08/22
17:29
08/22/17
17:29
Hot Stocks
Flotek announces conclusion of SEC inquiry »

Flotek Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 16

    May

CRM

Salesforce

$92.95

1.19 (1.30%)

17:24
08/22/17
08/22
17:24
08/22/17
17:24
Hot Stocks
Salesforce says 'had best quarter ever' »

Says can reach $20B in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

THO

Thor Industries

$103.90

0.45 (0.43%)

17:17
08/22/17
08/22
17:17
08/22/17
17:17
Hot Stocks
Jayco announces expansion of Middlebury campus, will add 300 jobs »

Jayco, a subsidiary of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$924.69

18.03 (1.99%)

, GOOGL

Alphabet Class A

$940.40

19.53 (2.12%)

17:14
08/22/17
08/22
17:14
08/22/17
17:14
Hot Stocks
Google introduces Chrome Enterprise »

Google introduced Chrome…

GOOG

Alphabet

$924.69

18.03 (1.99%)

GOOGL

Alphabet Class A

$940.40

19.53 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

VNET

21Vianet

$4.58

0.03 (0.66%)

17:11
08/22/17
08/22
17:11
08/22/17
17:11
Earnings
21Vianet reports Q2 EPS (12c), one estimate (11c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RTNB

root9B Technologies

$2.98

1.72 (136.51%)

17:05
08/22/17
08/22
17:05
08/22/17
17:05
Hot Stocks
root9B Technologies announces incremental funding, status of foreclosure »

root9B Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPT

Gramercy Property Trust

$29.13

-0.03 (-0.10%)

17:03
08/22/17
08/22
17:03
08/22/17
17:03
Hot Stocks
Gramercy Property Trust launches new JV over Class A distribution centers »

Gramercy Property Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.